Advertisement

Topics

Expert Predicts Promising Regimens Ahead in MCL

19:52 EDT 15 Sep 2018 | OncLive

The pipeline for relapsed/refractory mantle cell lymphoma treatment is beginning to evolve with novel agents and combination regimens that have the potential to improve patient outcomes.

Original Article: Expert Predicts Promising Regimens Ahead in MCL

NEXT ARTICLE

More From BioPortfolio on "Expert Predicts Promising Regimens Ahead in MCL"

Advertisement
Quick Search
Advertisement
Advertisement